Quantum Mitohormesis (QMT) (M2101)— 510(k) K240348

Name: FDA 510(k) clearance K240348
Creator: U.S. Food and Drug Administration
Published: 2024-12-19

Substantially Equivalent

Quantumtx Pte. , Ltd.

FDA 510(k) clearance K240348 for Quantum Mitohormesis (QMT) (M2101), Substantially Equivalent on 2024-12-19. Applicant: Quantumtx Pte. , Ltd.. Device class: 2.

Clearance details

Applicant: Quantumtx Pte. , Ltd.
Product code: Code IPF
Device class: Class 2
Regulation: 21 CFR 890.5850
Advisory panel: Physical Medicine
Date received: 2024-02-05
Decision date: 2024-12-19
Decision: Substantially Equivalent
Clearance type: Abbreviated
Location: Singapore, SG

Download summary PDF View on FDA.gov ↗

Recent devices under product code IPF

view all

K253542 — Apollo Quattro (APQ-10M)2026-06-08
K252816 — High Tone Power therapy (HiToP) (Model: HiToP PNP)2026-06-02
K260142 — StimelMD (SSMD) system2026-05-27
K251083 — Compact II2025-09-12
K241433 — EVE Synergy (EVE-20M)2025-06-04

Data sourced from openFDA. This site is unofficial and independent of the FDA.